Company profile

Suzhou Puhe Pharmaceutical Technology Co., LTD

Privately held: no public share price (Privately held, VC-backed (CAS Star, Hankang Capital and others); no IPO found. Caveat recorded by the research pass: overlapping entity names in the group make the exact match less than certain. [resolved 2026-08-05 by resolve-null-is-public; source: https://www.ventureradar.com/organisation/Suzhou%20Puhe%20Pharmaceutical%20Technology/366f020b-2400-45c4-a8af-cee1576875fd]) · China

Assets

(2 total)

2Total Assets

0Approved

1Phase 3 / Filed

1Phase 1–2 / Early

1Diseases

Showing 2 of 2 assets

		Target & Modality
YK-209A	Phase 3	EGFRSmall molecule	Non-Small Cell Lung Cancer
PH009-1	Phase 2	EGFRSmall molecule	Non-Small Cell Lung Cancer

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.